Cargando…
Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
MYC is a master transcriptional regulator that controls almost all cellular processes. Over the last several decades, researchers have strived to define the context-dependent transcriptional gene programs that are controlled by MYC, as well as the mechanisms that regulate MYC function, in an effort...
Autores principales: | Allen-Petersen, Brittany L., Sears, Rosalie C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790341/ https://www.ncbi.nlm.nih.gov/pubmed/31392631 http://dx.doi.org/10.1007/s40259-019-00370-5 |
Ejemplares similares
-
The use of protein phosphatase 2A activators in combination therapies for pancreas cancer
por: Allen-Petersen, Brittany L., et al.
Publicado: (2019) -
Targeting the MYC Ubiquitination-Proteasome Degradation Pathway for Cancer Therapy
por: Sun, Xiao-Xin, et al.
Publicado: (2021) -
Unraveling MYC’s Role in Orchestrating Tumor Intrinsic and Tumor Microenvironment Interactions Driving Tumorigenesis and Drug Resistance
por: Doha, Zinab O., et al.
Publicado: (2023) -
Writing and erasing MYC ubiquitination and SUMOylation
por: Chen, Yingxiao, et al.
Publicado: (2019) -
Therapeutic targeting of “undruggable” MYC
por: Llombart, Victor, et al.
Publicado: (2021)